The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
ArticleNo Access

GENERAL PARESIS IN SENILITY

Critical Review of the Literature and Clinico-Pathologic Report of Six Cases
Published Online:https://doi.org/10.1176/ajp.101.5.585

General paresis occurs in senility with considerable frequency. In the State of New York, about 10% of paretics admitted for the first time to state hospitals are 60 years old or more.

The incubation of the senile type of paresis is generally either extremely long (40-50 years), or rather short (5-7 years). The diagnosis is often made difficult by the fact that the blood serology is negative, in spite of the progress of the histologic inflammatory process.

Pathologic investigations revealed that these cases may be divided into two groups: the first group, by far less common, characterized by intense inflammatory changes, presence of alterations typical of senility, and absence of arteriosclerotic lesions; the second group characterized by milder inflammatory changes, absence of alterations typical of senility, and the almost constant presence of arteriosclerotic lesions.

Study of the interrelations between the paretic process, cerebral arteriosclerosis, and senility, seems to indicate that (1) the neuroluetic inflammatory process may have an inhibitory influence upon the neuropathologic changes of senility. On the other hand the senile process may have a stimulating influence upon the neuroluetic inflammation.

(2) Neurolues may accelerate the arteriosclerotic process of the brain. Cerebral arteriosclerotic changes in turn may tend to diminish the intensity of the inflammatory process.

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.